Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Pain, Intractable 1Mucositis 1Leukemia 1Inflammatory Bowel Diseases 1Diverticulitis 1Diverticular Diseases 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Breast Cancer Female 1Breakthrough Pain 1Bone Marrow Failure Disorders 1Bites and Stings 1Anemia, Aplastic 1Agnosia 1Acute Pain 1

Interventions

Fluorouracil 219Leucovorin 202Oxaliplatin 192Irinotecan 150Bevacizumab 110Capecitabine 94Cetuximab 90Folfox protocol 54Chemotherapy, Adjuvant 36Panitumumab 30Colonoscopy 30pembrolizumab 23Drug Therapy 23Nivolumab 22Magnetic Resonance Spectroscopy 22Gemcitabine 21Blood Specimen Collection 20Radiotherapy 19Floxuridine 19Biopsy 19Neoadjuvant Therapy 18Laparoscopy 18IFL protocol 18Early Intervention, Educational 18Celecoxib 18Surveys and Questionnaires 17Surgical Procedures, Operative 16Immunohistochemistry 16Exercise 16trifluridine tipiracil drug combination 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Passive Cutaneous Anaphylaxis × Clear all
NCT01477190 2011-11-28

Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 1/2 Completed
40 enrolled
Gastrointestinal

Colonic Neoplasms, Diverticulitis, Inflammatory Bowel Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡